InsidersTradesSigma
Track the Cohance Lifesciences Limited stock price and the full management transaction log of the company, a publicly traded company based in India. Shares are quoted on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Cohance Lifesciences Limited has logged 6 reports. Market capitalisation: €162.6bn. The latest transaction was reported on 19 September 2025 (Sale). Among the most active insiders: Jusmiral Holdings Limited. All data is free.
Analysts rate Cohance Lifesciences Limited Hold (neutral), based on 9 analysts. Average price target: ₹514.00.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
Cohance Lifesciences Limited is a company focused on the healthcare and pharmaceutical sector. It is listed on the XBOM.